Developer docs
API playgroundTry for free, no card

Search company profiles

BARRX Medical

Full company profile

uuid000g6pc

Namestring
BARRX Medical
Websiteurl
barrx.com
Company typeenum
Private
Founded yearint
2001
Short descriptiontext

BARRX Medical, founded in 2001 in Sunnyvale, California, develops gastrointestinal radiofrequency ablation technology used by gastroenterologists to treat Barrett's esophagus, and now operates as part of Medtronic's GI Solutions franchise.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSunnyvale, United States
HQ citystring
Sunnyvale
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
gastrointestinal RF ablation, Barrett's esophagus treatment, GI endoscopy devices, radiofrequency ablation systems, esophageal ablation therapy
Industry3 codes
1Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools)
CodeHLAHADANPrimaryYes
2Advanced Endoscopy (ERCP/EUS/Interventional)
CodeHLAKAEACPrimaryNo
3Gastrointestinal Oncology
CodeHLAKAFAKPrimaryNo
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Medical Devices — Gastrointestinal RF Ablation Systems
Social media profiles1 record
Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

BARRX Medical develops and manufactures radiofrequency (RF) ablation systems used by gastroenterologists during endoscopic procedures to treat Barrett's esophagus. The company focuses on the ongoing research and treatment of Barrett's esophagus for patients diagnosed with the disease, supplying proprietary GI ablation devices through the Medtronic (formerly Covidien) gastrointestinal product line.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Gastrointestinal RF Ablation System (BARRX)
No data
Peers10 records
TypeBroad incumbent
Description

BARRX's parent company and the operator of the COVIDIEN GI ablation franchise. Directly comparable as the owner of the BARRX platform and the largest medical device incumbent in endoscopic ablation.

TypeDirect peer
Description

Major endoscopy and GI device competitor with overlapping therapeutic portfolios (including its own Barrett's ablation and resection tools). Comparable end customers, business model, and procedural settings make it the most relevant direct competitor.

TypeBroad incumbent
Description

Dominant player in flexible endoscopy with a broad therapeutic accessory portfolio that competes with BARRX in advanced endoscopy procedure rooms. Serves the same gastroenterologist customer base with integrated endoscope-plus-device solutions.

TypeBroad incumbent
Description

Provides endoscopy and GI procedural devices and infection prevention solutions to hospitals and endoscopy centers, overlapping with BARRX's customer base and procedural workflows.

TypeDirect peer
Description

Endoscope manufacturer with a growing therapeutic device portfolio in GI, including tools relevant to Barrett's evaluation and treatment. Comparable as a specialist in flexible endoscopy and adjacent therapeutic accessories.

TypeDirect peer
Description

Manufactures endoscopic accessories and therapeutic devices used in advanced GI procedures, including tools used in Barrett's management and ERCP/EUS. Competes in the same hospital channels and procedure categories.

TypeEmerging player
Description

Medical device company with ablation and energy-based therapy offerings that intersect with BARRX's RF ablation technology base. Comparable as a mid-sized player developing therapeutic ablation solutions for adjacent indications.

TypeBroad incumbent
Description

Surgical and specialty medical device manufacturer with ablation and electrosurgery product lines that compete in adjacent energy-based therapy categories relevant to endoscopic tissue treatment.

TypeEmerging player
Description

German-based specialist in electrosurgery and endoscopic technology with VIO systems used in advanced GI therapeutic procedures. Comparable as an energy-device specialist competing for advanced endoscopy procedure room share.

TypeBroad incumbent
Description

Major endoscope and GI imaging vendor with a growing therapeutic accessory portfolio that addresses the same advanced endoscopy and Barrett's management use cases served by BARRX's ablation platform.

Market position
Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BARRX Medical

Medical Devices — Gastrointestinal RF Ablation Systemsbarrx.com

BARRX Medical, founded in 2001 in Sunnyvale, California, develops gastrointestinal radiofrequency ablation technology used by gastroenterologists to treat Barrett's esophagus, and now operates as part of Medtronic's GI Solutions franchise.

BARRX Medical firmographics

Firmographics
Name
BARRX Medical
Website
https://barrx.com
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
51–100 employees
Short description
BARRX Medical, founded in 2001 in Sunnyvale, California, develops gastrointestinal radiofrequency ablation technology used by gastroenterologists to treat Barrett's esophagus, and now operates as part of Medtronic's GI Solutions franchise.
Ownership category
akta.pro rank

BARRX Medical industry classification

Industry
Product category
Medical Devices — Gastrointestinal RF Ablation Systems
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN)
akta.pro secondary industries
Advanced Endoscopy (ERCP/EUS/Interventional) (HLAKAEAC), Gastrointestinal Oncology (HLAKAFAK)

Keywords

  • Gastrointestinal RF ablation
  • Barrett's esophagus treatment
  • GI endoscopy devices
  • Radiofrequency ablation systems
  • Esophageal ablation therapy

Where BARRX Medical is headquartered

Location

Headquarters

HQ city
Sunnyvale
HQ country
United States
HQ region
North America

Markets served

BARRX Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

BARRX Medical product offering

Product offering

Core offering

BARRX Medical develops and manufactures radiofrequency (RF) ablation systems used by gastroenterologists during endoscopic procedures to treat Barrett's esophagus. The company focuses on the ongoing research and treatment of Barrett's esophagus for patients diagnosed with the disease, supplying proprietary GI ablation devices through the Medtronic (formerly Covidien) gastrointestinal product line.

Differentiator

Problem solved

Functional benefit

Products and services

  • Gastrointestinal RF Ablation System (BARRX)

Companies that use BARRX Medical

Customer profile

Ideal customer profiles1 record

BARRX Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

BARRX Medical competitors and assessment

Company assessment

Broad incumbents

  • Medtronic (GI Solutions): BARRX's parent company and the operator of the COVIDIEN GI ablation franchise. Directly comparable as the owner of the BARRX platform and the largest medical device incumbent in endoscopic ablation.
  • Olympus Medical: Dominant player in flexible endoscopy with a broad therapeutic accessory portfolio that competes with BARRX in advanced endoscopy procedure rooms. Serves the same gastroenterologist customer base with integrated endoscope-plus-device solutions.
  • Steris (GI/Endoscopy): Provides endoscopy and GI procedural devices and infection prevention solutions to hospitals and endoscopy centers, overlapping with BARRX's customer base and procedural workflows.
  • Conmed: Surgical and specialty medical device manufacturer with ablation and electrosurgery product lines that compete in adjacent energy-based therapy categories relevant to endoscopic tissue treatment.
  • Fujifilm Healthcare (Endoscopy): Major endoscope and GI imaging vendor with a growing therapeutic accessory portfolio that addresses the same advanced endoscopy and Barrett's management use cases served by BARRX's ablation platform.

Direct peers

  • Boston Scientific: Major endoscopy and GI device competitor with overlapping therapeutic portfolios (including its own Barrett's ablation and resection tools). Comparable end customers, business model, and procedural settings make it the most relevant direct competitor.
  • Pentax Medical (HOYA): Endoscope manufacturer with a growing therapeutic device portfolio in GI, including tools relevant to Barrett's evaluation and treatment. Comparable as a specialist in flexible endoscopy and adjacent therapeutic accessories.
  • Cook Medical: Manufactures endoscopic accessories and therapeutic devices used in advanced GI procedures, including tools used in Barrett's management and ERCP/EUS. Competes in the same hospital channels and procedure categories.

Emerging players

  • AngioDynamics: Medical device company with ablation and energy-based therapy offerings that intersect with BARRX's RF ablation technology base. Comparable as a mid-sized player developing therapeutic ablation solutions for adjacent indications.
  • Erbe Elektromedizin: German-based specialist in electrosurgery and endoscopic technology with VIO systems used in advanced GI therapeutic procedures. Comparable as an energy-device specialist competing for advanced endoscopy procedure room share.

Market position

Customer concentration

BARRX Medical social profiles

Digital presence

BARRX Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BARRX Medical leadership team

Management profile

Number of profiles

Profiles1 record

BARRX Medical funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BARRX Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BARRX Medical

What does BARRX Medical do?

BARRX Medical develops and manufactures radiofrequency (RF) ablation systems used by gastroenterologists during endoscopic procedures to treat Barrett's esophagus. The company focuses on the ongoing research and treatment of Barrett's esophagus for patients diagnosed with the disease, supplying proprietary GI ablation devices through the Medtronic (formerly Covidien) gastrointestinal product line.

Is BARRX Medical a public or private company?

BARRX Medical is a private company. It is classified as corporate owned and is currently operating.

When was BARRX Medical founded?

BARRX Medical was founded in 2001. It employs 51 to 100 people.

Where is BARRX Medical based?

BARRX Medical is headquartered in Sunnyvale, United States, in the North America region.

Who are BARRX Medical's main competitors?

Broad incumbents on record are Medtronic (GI Solutions), Olympus Medical, Steris (GI/Endoscopy), Conmed and Fujifilm Healthcare (Endoscopy). Direct peers are Boston Scientific, Pentax Medical (HOYA) and Cook Medical. Emerging players are AngioDynamics and Erbe Elektromedizin.

Does BARRX Medical have an API?

No public API is recorded for BARRX Medical.

What industry is BARRX Medical in?

BARRX Medical's product category is Medical Devices — Gastrointestinal RF Ablation Systems. Its primary akta.pro industry code is HLAHADAN, Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools), with a secondary code of HLAKAEAC, Advanced Endoscopy (ERCP/EUS/Interventional). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals